Acoziborole: First Approval

Top related papers

1. SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis · Robert T. Jacobs · 2011 · 310 citations · Cited by this paper
2. The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020 · José R. Franco · 2022 · 197 citations · Cited by this paper
3. Clinical and veterinary trypanocidal benzoxaboroles target CPSF3 · Richard J. Wall · 2018 · 136 citations · Cited by this paper
4. Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial · Victor Kande Betu Kumeso · 2022 · 127 citations · Cited by this paper
5. Human African trypanosomiasis · Veerle Lejon · 2025 · 49 citations · Cited by this paper
6. Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis · Stephen A. Wring · 2013 · 37 citations · Cited by this paper
7. Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study · Antoine Tarral · 2023 · 34 citations · Cited by this paper
8. Clinically relevant benzoxaboroles inhibit mRNA processing in Trypanosoma brucei · Albina Waithaka · 2022 · 11 citations · Cited by this paper
9. Hypothesis-generating proteome perturbation to identify NEU-4438 and acoziborole modes of action in the African Trypanosome · Amrita Sharma · 2022 · 9 citations · Cited by this paper
10. Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans · Jean‐Yves Gillon · 2025 · 2 citations · Cited by this paper

Explore the research map

Source: OpenAlex (CC0)